Literature DB >> 15969780

Clinical value of C-reactive protein measurements in HIV-positive patients.

Mahdad Noursadeghi1, Robert F Miller.   

Abstract

The acute-phase protein C-reactive protein (CRP) is a sensitive marker of inflammation and tissue damage. We measured CRP in 109 HIV-1 antibody-positive patients admitted to hospital for investigation. In 67 patients with intercurrent infection (of whom 27 were afebrile at presentation) CRP levels were 2.2-483.5 mg/dL (normal value in the general population <3 mg/dL) and in 42 patients with alternative non-infection diagnoses CRP levels were 0.5-108.6 (median=5.9) mg/dL. Whereas in those with infections elevated CRP levels fell in response to specific therapy, values remained abnormal in those with non-infection diagnoses. CRP appears useful for diagnosis and monitoring of intercurrent infection in HIV-1 antibody-positive patients. In HIV-1 antibody-positive patients without intercurrent infection, CRP values higher than in the general population possibly reflect a sustained acute-phase response as a consequence of HIV infection per se.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15969780     DOI: 10.1258/0956462054094006

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  13 in total

1.  Association of C-reactive protein and HIV infection with acute myocardial infarction.

Authors:  Virginia A Triant; James B Meigs; Steven K Grinspoon
Journal:  J Acquir Immune Defic Syndr       Date:  2009-07-01       Impact factor: 3.731

2.  Usefulness of alternate prognostic serum and plasma markers for antiretroviral therapy for human immunodeficiency virus type 1 infection.

Authors:  R Kannangai; A J Kandathil; D L Ebenezer; E Mathai; A J Prakash; O C Abraham; T D Sudarsanam; S A Pulimood; R Selvakumar; V Job; G Sridharan
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

3.  C-reactive protein independently predicts HIV-related outcomes among women and children in a resource-poor setting.

Authors:  Paul K Drain; Roland Kupka; Gernard I Msamanga; Willy Urassa; Ferdinand Mugusi; Wafaie W Fawzi
Journal:  AIDS       Date:  2007-10-01       Impact factor: 4.177

4.  The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study.

Authors:  Andrea De Luca; Katleen de Gaetano Donati; Manuela Colafigli; Alessandro Cozzi-Lepri; Amalia De Curtis; Andrea Gori; Laura Sighinolfi; Andrea Giacometti; Maria Rosaria Capobianchi; Alessandro D'Avino; Licia Iacoviello; Roberto Cauda; Antonella D'Arminio Monforte
Journal:  BMC Infect Dis       Date:  2013-09-03       Impact factor: 3.090

Review 5.  C-Reactive Protein as an Independent Cardiovascular Risk Predictor in HIV+ Patients: A Focused Review of Published Studies.

Authors:  Tarvinder S Gilotra; Stephen A Geraci
Journal:  J Clin Med Res       Date:  2017-10-02

6.  Comparison of pathological clotting using haematological, functional and morphological investigations in HIV-positive and HIV-negative patients with deep vein thrombosis.

Authors:  Brandon S Jackson; Julien Nunes Goncalves; Etheresia Pretorius
Journal:  Retrovirology       Date:  2020-06-22       Impact factor: 4.602

7.  Prevention of atherosclerosis in patients living with HIV.

Authors:  Ferruccio De Lorenzo; Marta Boffito; Sophie Collot-Teixeira; Brian Gazzard; John L McGregor; Kevin Shotliff; Han Xiao
Journal:  Vasc Health Risk Manag       Date:  2009-04-08

8.  HIV infection and drugs of abuse: role of acute phase proteins.

Authors:  Thangavel Samikkannu; Kurapati V K Rao; Adriana Y Arias; Aarthi Kalaichezian; Vidya Sagar; Changwon Yoo; Madhavan P N Nair
Journal:  J Neuroinflammation       Date:  2013-09-17       Impact factor: 8.322

9.  Exosome markers associated with immune activation and oxidative stress in HIV patients on antiretroviral therapy.

Authors:  Sukrutha Chettimada; David R Lorenz; Vikas Misra; Simon T Dillon; R Keith Reeves; Cordelia Manickam; Susan Morgello; Gregory D Kirk; Shruti H Mehta; Dana Gabuzda
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

Review 10.  Cardiac Steatosis in HIV-A Marker or Mediator of Disease?

Authors:  Morgan Jacob; Cameron J Holloway
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-11       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.